1
0
0
(1 - 32 von 43
)
journal of medicineDickyRicky
dickyricky.com
von W Hacke · · Zitiert von: — Thomas Machnig, M.D., Dietmar Schneider, M.D., Rüdiger von Kummer, M.D., Nils Wahlgren, M.D., and Danilo Toni, M.D., for the ECASS ...
Population Pharmacokinetics of Eniporide and Its Metabolite ...Wiley
accp1.onlinelibrary.wiley.com
von VA Bhattaram · · Zitiert von: 3 — Dr Thomas Machnig MD,. Dr Thomas Machnig MD. Department of Clinical Sciences, Merck KGaA, Darmstadt, Germany. Search for more papers by this ... von VA Bhattaram · · Zitiert von: 3 — Dr Thomas Machnig MD,. Dr Thomas Machnig MD. Department of Clinical Sciences, Merck KGaA, Darmstadt, Germany. Search for more papers by this ...
Accepted ManuscriptAIR Unimi
air.unimi.it
von M Cicardi · · Zitiert von: 2 — Wu, M.D., Thomas Machnig, M.D., Annalisa De Silvestri, M.D., Mario Regazzi,. Pharm.D., Carmine Tinelli, M.D.. PII: S (16) DOI: j.jaci ... von M Cicardi · · Zitiert von: 2 — Wu, M.D., Thomas Machnig, M.D., Annalisa De Silvestri, M.D., Mario Regazzi,. Pharm.D., Carmine Tinelli, M.D.. PII: S (16) DOI: j.jaci ...
Wileyhttps://ascpt.onlinelibrary.wiley.com › ...Exposure‐Response Model of Subcutaneous C1‐Inhibitor ...
ascpt.onlinelibrary.wiley.com
von Y Zhang · · Zitiert von: 17 — Thomas Machnig,. Thomas Machnig. Department of Global Clinical Development/Medical Affairs, CSL Behring GmbH, Marburg, Germany. Search for more ...
Comparative Economics of On-Demand Treatment Options ...Journal of Allergy and Clinical Immunology
www.jacionline.org
von Z Panahloo · · Zitiert von: 5 — Zoya Panahloo. Zoya Panahloo. Affiliations. CSL Behring UK Ltd, Haywards Heath, United Kingdom · Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, ... von Z Panahloo · · Zitiert von: 5 — Zoya Panahloo. Zoya Panahloo. Affiliations. CSL Behring UK Ltd, Haywards Heath, United Kingdom · Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, ...
Health-Related Quality of Life with Subcutaneous C1 ...ScienceDirect.com
www.sciencedirect.com
von WR Lumry · · Zitiert von: 80 — ... MD, PhD, DSc q , John-Philip Lawo MSc r , Ingo Pragst PhD r , Thomas Machnig MD, MBA r , Douglas J. Watson PhD s. Show more. Add to Mendeley. Share. Cite. von WR Lumry · · Zitiert von: 80 — ... MD, PhD, DSc q , John-Philip Lawo MSc r , Ingo Pragst PhD r , Thomas Machnig MD, MBA r , Douglas J. Watson PhD s. Show more. Add to Mendeley. Share. Cite.
Clinical features of genetically characterized types of ...Orphanet Journal of Rare Diseases
ojrd.biomedcentral.com
von K Bork · · Zitiert von: 97 — Konrad Bork reports speaker fees from CSL Behring and Shire/Takeda, outside the submitted work; Thomas Machnig is a former employee of CSL ... von K Bork · · Zitiert von: 97 — Konrad Bork reports speaker fees from CSL Behring and Shire/Takeda, outside the submitted work; Thomas Machnig is a former employee of CSL ...
Archive ouverte HAL
hal.science
von RL Sacco · · Zitiert von: — ... Thomas Machnig (3) , Prem Pais (24) , Robin Roberts (25) , Veronika Skvortsova (26) , Philip Teal (27) , Danilo Toni (28) , Cam Vandermaelen (5) , Thor ...
The Na+/H+exchange inhibitor eniporide as an adjunct to ...ScienceDirect.com
www.sciencedirect.com
von U Zeymer · · Zitiert von: 420 — ... , FACC †† , Rolf Tiemann ‡‡ , Thomas Machnig MD ‡‡ , Karl-Ludwig Neuhaus MD * , for the ESCAMI Investigators. Show more. Add to Mendeley. Share. Cite. von U Zeymer · · Zitiert von: 420 — ... , FACC †† , Rolf Tiemann ‡‡ , Thomas Machnig MD ‡‡ , Karl-Ludwig Neuhaus MD * , for the ESCAMI Investigators. Show more. Add to Mendeley. Share. Cite.
Per-Attack Reporting of Prodromal Symptoms Concurrent ...Springer
link.springer.com
von MJ Prematta · · Zitiert von: 40 — Thomas Machnig. Penn State University College of Medicine, Hershey, Pennsylvania, USA. Timothy J. Craig. Authors. Michael J. Prematta. View ... von MJ Prematta · · Zitiert von: 40 — Thomas Machnig. Penn State University College of Medicine, Hershey, Pennsylvania, USA. Timothy J. Craig. Authors. Michael J. Prematta. View ...
Springer
link.springer.com
von MJ Prematta · · Zitiert von: 40 — Thomas Machnig ∙ Timothy J. Craig. To view enhanced content go to www.advancesintherapy.com. Received: July 26, Published online ...
The new england journal of medicineCerebrovaskulární manuál
www.manual-cmp.cz
von W Hacke · · Zitiert von: — Thomas Machnig, M.D., Dietmar Schneider, M.D., Rüdiger von Kummer, M.D., Nils Wahlgren, M.D., and Danilo Toni, M.D., for the ECASS ...
C1-inhibitor therapy for hereditary angioedema attacksNational Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von AK Bewtra · · Zitiert von: 31 — Authors. Againdra K Bewtra , Robyn J Levy, Kraig W Jacobson, Richard L Wasserman, Thomas Machnig, Timothy J Craig. Affiliation. 1 Division of Allergy and ... von AK Bewtra · · Zitiert von: 31 — Authors. Againdra K Bewtra , Robyn J Levy, Kraig W Jacobson, Richard L Wasserman, Thomas Machnig, Timothy J Craig. Affiliation. 1 Division of Allergy and ...
Creighton ResearchWorks
researchworks.creighton.edu
von MJ Prematta · · Zitiert von: 40 — Thomas MacHnig and Timothy J. Craig Show details for 7 authors. Advances in Therapy, Vol.29(10), pp DOI: https://doi.org s
Evaluation of the Safety and Cardioprotective Effects ...Karger Publishers
karger.com
von U Zeymer · · Zitiert von: 11 — Thomas Machnig;. Thomas Machnig. aMedizinische Klinik II, Klinikum Kassel, Kassel, Germany; bZiekenhuis De Weezenlande, Zwolle, The Netherlands; cHôpital ... von U Zeymer · · Zitiert von: 11 — Thomas Machnig;. Thomas Machnig. aMedizinische Klinik II, Klinikum Kassel, Kassel, Germany; bZiekenhuis De Weezenlande, Zwolle, The Netherlands; cHôpital ...
JACC Journals
www.jacc.org
von U Zeymer · · Zitiert von: 418 — Thomas Machnig,; Karl-Ludwig Neuhaus, and; for the ESCAMI Investigators. Uwe Zeymer. Medizinische Klinik II, Klinikum Kassel, Kassel, Germany. Search for more ...
Effect of time to treatment on response to C1 esterase ...Penn State
pure.psu.edu
von TJ Craig · · Zitiert von: 65 — Rojavin, Thomas Machnig, Heinz Otto Keinecke, Jonathan A. Bernstein. Department of Medicine · Division of Pulmonary, Allergy and Critical Care Medicine ... von TJ Craig · · Zitiert von: 65 — Rojavin, Thomas Machnig, Heinz Otto Keinecke, Jonathan A. Bernstein. Department of Medicine · Division of Pulmonary, Allergy and Critical Care Medicine ...
Health-Related Quality of Life with Subcutaneous C Johns Hopkins University
pure.johnshopkins.edu
von WR Lumry · · Zitiert von: 80 — ... Thomas Machnig, Douglas J. Watson. Research output: Contribution to journal › Article › peer-review. 34 Scopus citations. Overview · Fingerprint ... von WR Lumry · · Zitiert von: 80 — ... Thomas Machnig, Douglas J. Watson. Research output: Contribution to journal › Article › peer-review. 34 Scopus citations. Overview · Fingerprint ...
Healthcare utilization of patients with hereditary ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von MA Riedl · · Zitiert von: 3 — ... Thomas Machnig , Aleena Banerji. Affiliations. 1 From the Division of Rheumatology, Allergy & Immunology, University of California San ... von MA Riedl · · Zitiert von: 3 — ... Thomas Machnig , Aleena Banerji. Affiliations. 1 From the Division of Rheumatology, Allergy & Immunology, University of California San ...
Journal of Allergy and Clinical Immunology
www.jacionline.org
von K Bork · · Zitiert von: 1 — Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, Marburg, Germany. Search for articles by this author. Timothy J. Craig, DO FAAAAI. Timothy J ...
Per-Attack Reporting of Prodromal Symptoms Concurrent with ...Creighton University
researchworks.creighton.edu
von MJ Prematta · · Zitiert von: 40 — Michael J. Prematta, Againdra K. Bewtra, Robyn J. Levy, Richard L. Wasserman, Kraig W. Jacobson, Thomas Machnig and Timothy J. Craig von MJ Prematta · · Zitiert von: 40 — Michael J. Prematta, Againdra K. Bewtra, Robyn J. Levy, Richard L. Wasserman, Kraig W. Jacobson, Thomas Machnig and Timothy J. Craig
Monash University
research.monash.edu
von S Yusuf · · Zitiert von: — ... Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, Cam VanderMaelen, Thor Voigt, Michael Weber, Byung-Woo Yoon ...
Patient satisfaction and experience with intravenously ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von MA Riedl · · Zitiert von: 34 — ... Thomas Machnig. Affiliations. 1 University of California-San Diego, La Jolla, California. Electronic address: . 2 Massachusetts General ... von MA Riedl · · Zitiert von: 34 — ... Thomas Machnig. Affiliations. 1 University of California-San Diego, La Jolla, California. Electronic address: . 2 Massachusetts General ...
Thrombolysis with alteplase 3 to 4.5 hours after acute ...Helsinki.fi
researchportal.helsinki.fi
von W Hacke · · Zitiert von: — ... Thomas Machnig, Dietmar Schneider, Rudiger von Kummer, Nils Wahlgren, Danilo Toni, ECASS Investigators. Neurologian yksikkö. Research output: Contribution to ... von W Hacke · · Zitiert von: — ... Thomas Machnig, Dietmar Schneider, Rudiger von Kummer, Nils Wahlgren, Danilo Toni, ECASS Investigators. Neurologian yksikkö. Research output: Contribution to ...
Consequences of a New Treatment Paradigm in DenmarkMedical Journals Sweden
medicaljournalssweden.se
von A Bygum · · Zitiert von: 56 — ... Aleena Banerji, Richard G. Gower, Henriette Farkas, John-Philip Lawo, Ingo Pragst, Thomas Machnig, Douglas J. Watson (2018) — Marc A Riedl, Aleena Banerji, Michael E Manning, Earl Burrell, Namita Joshi, Dipen Patel, Thomas Machnig, Ming-Hui Tai, Douglas J Watson ...
Cl-inhibitor therapy for hereditary angioedema attacksebsco
search.ebscohost.com
von AK Bewtra · · Zitiert von: 32 — Againdra K. Bewtra, M.D.,^ Robyn J. Levy, M.D.,^ Kraig W. Jacobson, M.D.,^. Richard L. Wasserman, M.D.,* Thomas Machnig, M.D.,^ and Timothy J. Craig, D.O.^.
Effects of aspirin plus extended-release dipyridamole ...Monash University
research.monash.edu
von HC Diener · · Zitiert von: 408 — Karin Hermansson, Lutz Hilbrich, Markku Kaste, Chuanzhen Lu, Thomas Machnig, Prem Pais, Robin Roberts, Veronika Skvortsova, Philip Teal, Danilo Toni, ...
Health-Related Quality of Life with Subcutaneous C1 ...Pennsylvania State University
pure.psu.edu
von WR Lumry · · Zitiert von: 75 — ... Teresa Caballero, Aleena Banerji, Richard G. Gower, Henriette Farkas, John Philip Lawo, Ingo Pragst, Thomas Machnig, Douglas J. Watson.
Long-term health-related quality of life in patients treated ...Europe PMC
europepmc.org
von WR Lumry · · Zitiert von: 13 — ... Manning,15 Marc A. Riedl,16 John-Philip Lawo,17 Subhransu Prusty,17Thomas Machnig,17 Hilary Longhurst,18,19 and on behalf of the COMPACT Investigators ...
Population pharmacokinetics of eniporide and its ...Gale
go.gale.com
von VA Bhattaram · · Zitiert von: 3 — Authors: Venkatesh Atul Bhattaram, Nelamangala V. Nagaraja, Tanja Peters, Thomas Machnig, Sonja Kroesser and Andreas Kovar. Date: June
Telmisartan to Prevent Recurrent Stroke and Cardiovascular ...Nottingham Repository
nottingham-repository.worktribe.com
von S Yusuf · Zitiert von: — Thomas Machnig. Prem Pais. Robin Roberts. Veronika Skvortsova. Philip Teal. Danilo Toni. Cam VanderMaelen. Thor Voight. Michael Weber. Byung-Woo Yoon ...
Telmisartan to prevent recurrent stroke and cardiovascular ...Northwestern Scholars
www.scholars.northwestern.edu
von PRoFESS Study Group · · Zitiert von: — ... and Chuanzhen Lu and Thomas Machnig and Prem Pais and Robin Roberts and Veronika Skvortsova and Philip Teal and Danilo Toni and Maelen, ...
Alle Infos zum Namen "Thomas MacHnig"
sortiert nach Relevanz / Datum